Inhibition of the Renin Angiotensin System During Autologous Stem Cell Transplant Does Not Impact Time to Engraftment

Open Journal of Blood Diseases
doi 10.4236/ojbd.2012.24013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Controversies of Renin–angiotensin System Inhibition During the COVID-19 Pandemic

Nature Reviews Nephrology
Nephrology
2020English

Pegfilgrastim in Autologous Stem Cell Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Tbo-Filgrastim Versus Filgrastim During Mobilization and Neutrophil Engraftment in Autologous Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Renin Gene Polymorphisms and Haplotypes, Blood Pressure, and Responses to Renin-Angiotensin System Inhibition

Hypertension
Internal Medicine
2007English

Impact of Tandem Autologous Stem Cell Transplantation and Response to Transplant in the Outcome of Multiple Myeloma

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2012English

Inhibition of the Renin–angiotensin System and Target Organ Protection

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2009English

The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition

Journal of Managed Care Pharmacy
2007English

Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels Among Peritoneal Dialysis Patients

American Journal of Nephrology
Nephrology
2017English

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy